Patients with atrial fibrillation and a CHA 2 DS 2 -VASc score of 1: Are they at low or high stroke risk?

Journal of the American College of Cardiology

Volumn 65, Issue 14, 2015, Pages 1395-1397

  Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

anticoagulants; aspirin; vitamin K; warfarin

Indexed keywords

ARTERY EMBOLISM; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE ASSESSMENT; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; HEART ATRIUM FIBRILLATION; HUMAN; LUNG EMBOLISM; NOTE; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; TRANSIENT ISCHEMIC ATTACK; VALIDATION PROCESS; ATRIAL FIBRILLATION; FEMALE; MALE; STROKE;

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; STROKE;

EID: 84926408080     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.02.010     Document Type: Editorial

References (14)

1. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have non-valvular atrial fibrillation Ann Intern Med 146 2007 857 867
2. A.J. Camm, G.Y. Lip, and R. De Caterina 2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation Eur Heart J 33 2012 2719 2747
3. C.T. January, L.S. Wann, and J.S. Alpert 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 2014 e1 e76
4. D.E. Singer, Y. Chang, and M.C. Fang The net clinical benefit of warfarin anticoagulation in atrial fibrillation Ann Intern Med 151 2009 297 305
5. L. Friberg, M. Rosenqvist, and G.Y. Lip Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study Circulation 125 2012 2298 2307
6. M.H. Eckman, D.E. Singer, and J. Rosand Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation Circ Cardiovasc Qual Outcomes 4 2011 14 21
7. 2 -VASc score of 1 J Am Coll Cardiol 65 2015 225 232
8. 2 -VASc score J Am Coll Cardiol 65 2015 1385 1394
9. J.B. Olesen, G.Y. Lip, and M.L. Hansen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
10. G.Y. Lip, R. Nieuwlaat, and R. Pisters Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation Chest 137 2010 263 272
11. J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
12. G.Y. Lip, L. Frison, and J.L. Halperin Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort Stroke 41 2010 2731 2738
13. A.K. Kakkar, I. Mueller, and J.P. Bassand International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD) Am Heart J 163 2012 13 19.e1
14. M.V. Huisman, G.Y. Lip, and H.C. Diener Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation Am Heart J 167 2014 329 334